| Authors: |
Fort L; CRUK Beatson Institute, Glasgow, UK.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK., Batista JM; CRUK Beatson Institute, Glasgow, UK.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK., Thomason PA; CRUK Beatson Institute, Glasgow, UK., Spence HJ; CRUK Beatson Institute, Glasgow, UK., Whitelaw JA; CRUK Beatson Institute, Glasgow, UK., Tweedy L; CRUK Beatson Institute, Glasgow, UK., Greaves J; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Martin KJ; CRUK Beatson Institute, Glasgow, UK., Anderson KI; CRUK Beatson Institute, Glasgow, UK.; Francis Crick Institute, London, UK., Brown P; CRUK Beatson Institute, Glasgow, UK., Lilla S; CRUK Beatson Institute, Glasgow, UK., Neilson MP; CRUK Beatson Institute, Glasgow, UK., Tafelmeyer P; Hybrigenics Services, Paris, France., Zanivan S; CRUK Beatson Institute, Glasgow, UK., Ismail S; CRUK Beatson Institute, Glasgow, UK.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK., Bryant DM; CRUK Beatson Institute, Glasgow, UK.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK., Tomkinson NCO; WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK., Chamberlain LH; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Mastick GS; Department of Biology, University of Nevada, Reno, NV, USA., Insall RH; CRUK Beatson Institute, Glasgow, UK. r.insall@beatson.gla.ac.uk.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK. r.insall@beatson.gla.ac.uk., Machesky LM; CRUK Beatson Institute, Glasgow, UK. l.machesky@beatson.gla.ac.uk.; University of Glasgow Institute of Cancer Sciences, Glasgow, UK. l.machesky@beatson.gla.ac.uk. |
